BioVaxys Technology ( ($TSE:BIOV) ) just unveiled an announcement. BioVaxys’ 2025 corporate review highlights the integration of the DPX platform ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.

Nuvalent has reported phase 1/2 lung cancer data, teeing the biotech up to talk to the FDA about an approval filing that could establish its neladalkib as a challenger to Pfizer’s Lorbrena. The ALKOVE ...

Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...

“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...

Cancer registrars throughout the world will join their colleagues, fellow medical professionals, and community leaders to observe the 25th annual National Cancer Registrars Week (NCRW), April 5–9, ...

A new study reveals an alarming bias present in four leading AI cancer screening tools, related to race, gender, and age.

A farmer, diagnosed with bowel cancer at just 33, is urging young people to get potential symptoms checked. James Rogers, who ...